Hypoalbuminemia increases lysophosphatidylcholine in low-density lipoprotein of normocholesterolemic subjects.BackgroundA phospholipid, lysophosphatidylcholine (LPC), is the major determinant of the atherosclerotic properties of oxidized low-density lipoprotein (LDL). Under normal circumstances most LPC is bound to albumin. We hypothesized that lipoprotein LPC concentrations are increased in hypoalbuminemic patients with the nephrotic syndrome, irrespective of their lipid levels. To test this hypothesis, we selected nephrotic and control subjects with matched LDL cholesterol levels.MethodsLipoproteins and the albumin-rich lipoprotein-deficient fractions were separated by ultracentrifugation and their phospholipid composition was analyzed by...
• Objective: To examine the influence of the nephrotic syndrome on lipoprotein(a) [Lp(a)], a plasma ...
Very low-density lipoprotein-apoprotein CI is increased in diabetic nephropathy: Comparison with apo...
Nephrotic syndrome results in hyperlipidemia and profound alterations in lipid and lipoprotein metab...
Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results...
Increased very low density lipoprotein (VLDL) in nephrotic patients results from a decreased catabol...
OBJECTIVE: To examine the influence of the nephrotic syndrome on lipoprotein(a) [Lp(a)], a plasma li...
Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephr...
Lipoprotein(a)- and low-density lipoprotein–derived cholesterol in nephrotic syndrome: Impact on lip...
Lipoprotein(a) levels in relation to albumin concentration in childhood nephrotic syndrome.Backgroun...
Metabolism of apolipoprotein B-containing lipoproteins in subjects with nephrotic-range proteinuria....
Hyperlipidemia in the nephrotic syndrome results from increased synthesis and decreased catabolism o...
The elevated level of plasma low density lipoprotein (LDL) in hyperlipidemic patients is an importan...
Background and Methods: Patients with the nephrotic syndrome characteristically have multiple abnorm...
New insights into lipid metabolism in the nephrotic syndrome. Hyperlipidemia in the nephrotic syndro...
Patients with nephrotic-range proteinuria have apolipoprotein C and E deficient VLDL1.BackgroundImpa...
• Objective: To examine the influence of the nephrotic syndrome on lipoprotein(a) [Lp(a)], a plasma ...
Very low-density lipoprotein-apoprotein CI is increased in diabetic nephropathy: Comparison with apo...
Nephrotic syndrome results in hyperlipidemia and profound alterations in lipid and lipoprotein metab...
Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results...
Increased very low density lipoprotein (VLDL) in nephrotic patients results from a decreased catabol...
OBJECTIVE: To examine the influence of the nephrotic syndrome on lipoprotein(a) [Lp(a)], a plasma li...
Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephr...
Lipoprotein(a)- and low-density lipoprotein–derived cholesterol in nephrotic syndrome: Impact on lip...
Lipoprotein(a) levels in relation to albumin concentration in childhood nephrotic syndrome.Backgroun...
Metabolism of apolipoprotein B-containing lipoproteins in subjects with nephrotic-range proteinuria....
Hyperlipidemia in the nephrotic syndrome results from increased synthesis and decreased catabolism o...
The elevated level of plasma low density lipoprotein (LDL) in hyperlipidemic patients is an importan...
Background and Methods: Patients with the nephrotic syndrome characteristically have multiple abnorm...
New insights into lipid metabolism in the nephrotic syndrome. Hyperlipidemia in the nephrotic syndro...
Patients with nephrotic-range proteinuria have apolipoprotein C and E deficient VLDL1.BackgroundImpa...
• Objective: To examine the influence of the nephrotic syndrome on lipoprotein(a) [Lp(a)], a plasma ...
Very low-density lipoprotein-apoprotein CI is increased in diabetic nephropathy: Comparison with apo...
Nephrotic syndrome results in hyperlipidemia and profound alterations in lipid and lipoprotein metab...